Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.
After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback